Studies have also elucidated that LINRIS inhibits IGF2BP2 degradation in CRC HCT116 cells by inhibiting K139 ubiquitination, thereby promoting downstream MYC‐mediated glycolysis and tumor proliferation. Here, IGF2BP2 is linked to neoplasm.